Adherence to omalizumab: A multicenter 'real-world' study
Background: Adherence to medications is crucial in patients with severe asthma in light of the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not been well studied in real-world settings. The aim of this study was to assess adherence to omalizumab and evaluate treat...
Main Authors: | Raffaele Campisi, Claudia Crimi, Rossella Intravaia, Simona Strano, Alberto Noto, Maria Pia Foschino, Giuseppe Valenti, Vittorio Viviano, Corrado Pelaia, Luisa Ricciardi, Nicola Scichilone, Nunzio Crimi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-02-01
|
Series: | World Allergy Organization Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1939455120300065 |
Similar Items
-
Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use [version 2; peer review: 2 approved]
by: Santi Nolasco, et al.
Published: (2020-07-01) -
Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities
by: Claudia Crimi, et al.
Published: (2020-09-01) -
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy
by: Giovanna Elisiana Carpagnano, et al.
Published: (2020-06-01) -
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
by: Giovanna Elisiana Carpagnano, et al.
Published: (2021-03-01) -
Practical considerations for spirometry during the COVID-19 outbreak: Literature review and insights
by: Claudia Crimi, et al.
Published: (2021-09-01)